<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of riluzole, a putative inhibitor of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release, on the histological and neurobehavioral consequences of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> were tested in Sprague-Dawley rats </plain></SENT>
<SENT sid="1" pm="."><plain>Neurobehavioral studies (neurological examination, passive avoidance task) were carried out with sham-operated and occluded rats </plain></SENT>
<SENT sid="2" pm="."><plain>Riluzole 4 and 8 mg/kg administered 30 min after occlusion reduced (P &lt; 0.01) the cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> (respectively 94 +/- 12 mm3 and 73 +/- 15 mm3 versus 139 +/- 8 mm3 for control rats) </plain></SENT>
<SENT sid="3" pm="."><plain>Striatum <z:mp ids='MP_0001651'>necrosis</z:mp> was not modified by the low dosage (46 +/- 3 mm3 versus 49 +/- 3 mm3 for control rats), whereas the high dosage increased it (61 +/- 3 mm3, P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced neurological and <z:hpo ids='HP_0002354'>memory impairments</z:hpo> were not improved by riluzole </plain></SENT>
<SENT sid="5" pm="."><plain>Our results indicate that a drug depressing glutamatergic neurotransmission without blocking the <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptors exerts anti-ischemic activity </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, the results highlight the need for carrying out histological and neurobehavioral studies in parallel in this model </plain></SENT>
</text></document>